$PTIE, 17 institutional investors are raising
Post# of 23113
(Total Views: 603)
Posted On: 04/18/2017 9:18:22 AM
$PTIE,
17 institutional investors are raising stakes in Pain Therapeutics, Inc. (PTIE)
April 18, 2017
Pain Therapeutics, Inc. (NASDAQ
TIE) reached 56.83% versus a 1-year low price of $0.51. The stock was last seen -2.95% lower, reaching at $0.8 on Apr. 17, 2017. At recent session, the prices were hovering between $0.79 and $0.84. This company shares are 337.5% off its target price of $3.5 and the current market capitalization stands at $36.9M. The recent change has given its price a 13.15% lead over SMA 50 and -73.33% deficit over its 52-week high. The stock witnessed 14.04% gains, 33.27% gains and 3.76% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found PTIE’s volatility during a week at 7.85% and during a month it has been found around 13.03%.
Pain Therapeutics, Inc. (PTIE) Top Holders
Institutional investors currently hold around $16 million or 41.9% in PTIE stock. Look at its top three institutional owners. First Eagle Investment Management, Llc owns $5.44 million in Pain Therapeutics, Inc., which represents roughly 14.75% of the company’s market cap and approximately 34.01% of the institutional ownership. Similar statistics are true for the second largest owner, Nantahala Capital Management, Llc, which owns 3,429,353 shares of the stock are valued at $2.83 million. The third largest holder is Bvf Inc/Il, which currently holds $1.88 million worth of this stock and that ownership represents nearly 5.09% of its market capitalization.
Pain Therapeutics, Inc. 13F Filings
At the end of 12/31/2016 reporting period, 17 institutional holders increased their position in Pain Therapeutics, Inc. (NASDAQ TIE) by some 982,906 shares, 23 decreased positions by 2,692,129 and 13 held positions by 15,478,982. That puts total institutional holdings at 19,154,017 shares, according to SEC filings. The stock grabbed 5 new institutional investments totaling 688,079 shares while 7 institutional investors sold out their entire positions totaling 921,328 shares.
Pain Therapeutics, Inc. (NASDAQ TIE) Insider Trades
Multiple company employees have indulged in significant insider trading. Pain Therapeutics, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director ROBERTSON SANFORD has acquired 50,000 shares of Pain Therapeutics, Inc. (PTIE) in trading session dated Nov. 06, 2013. These shares are worth $186,500 and were traded at $3.73 each. The SEC filing shows that FRIEDMANN NADAV performed a sale of 25,000 shares. The COO disposed these shares by way of transaction on Oct. 18, 2011. The company’s shares were given away at $4.44 per share worth to an income of some $111,000 on account of FRIEDMANN NADAV.
COO, FRIEDMANN NADAV, sold 25,000 common shares of Pain Therapeutics, Inc. (PTIE) in the open market. In a transaction dated Oct. 04, 2011, the shares were put up for sale at an average price of $4.81, raking in a sum of $120,250. After this sale, 284,255 common shares of PTIE are directly owned by the insider, with total stake valued at $227,404.
In the transaction dated Oct. 04, 2011, the great number of shares disposed came courtesy the 10% Owner; Sabretooth Master Fund, L.P. disposed a total of 382,000 shares at an average price of $4.59, amounting to approximately $1,753,380. The insider now directly owns 4,263,076 shares worth $3,410,461.
Pain Therapeutics, Inc. (PTIE) Analyst Guide
Several analysts have released their opinion on Pain Therapeutics, Inc. (NASDAQ TIE), with 0 analysts believing it is a strong buy. Whereas 1 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 3 average brokerage recommendation.
17 institutional investors are raising stakes in Pain Therapeutics, Inc. (PTIE)
April 18, 2017
Pain Therapeutics, Inc. (NASDAQ
TIE) reached 56.83% versus a 1-year low price of $0.51. The stock was last seen -2.95% lower, reaching at $0.8 on Apr. 17, 2017. At recent session, the prices were hovering between $0.79 and $0.84. This company shares are 337.5% off its target price of $3.5 and the current market capitalization stands at $36.9M. The recent change has given its price a 13.15% lead over SMA 50 and -73.33% deficit over its 52-week high. The stock witnessed 14.04% gains, 33.27% gains and 3.76% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found PTIE’s volatility during a week at 7.85% and during a month it has been found around 13.03%. Pain Therapeutics, Inc. (PTIE) Top Holders
Institutional investors currently hold around $16 million or 41.9% in PTIE stock. Look at its top three institutional owners. First Eagle Investment Management, Llc owns $5.44 million in Pain Therapeutics, Inc., which represents roughly 14.75% of the company’s market cap and approximately 34.01% of the institutional ownership. Similar statistics are true for the second largest owner, Nantahala Capital Management, Llc, which owns 3,429,353 shares of the stock are valued at $2.83 million. The third largest holder is Bvf Inc/Il, which currently holds $1.88 million worth of this stock and that ownership represents nearly 5.09% of its market capitalization.
Pain Therapeutics, Inc. 13F Filings
At the end of 12/31/2016 reporting period, 17 institutional holders increased their position in Pain Therapeutics, Inc. (NASDAQ
TIE) by some 982,906 shares, 23 decreased positions by 2,692,129 and 13 held positions by 15,478,982. That puts total institutional holdings at 19,154,017 shares, according to SEC filings. The stock grabbed 5 new institutional investments totaling 688,079 shares while 7 institutional investors sold out their entire positions totaling 921,328 shares. Pain Therapeutics, Inc. (NASDAQ
TIE) Insider Trades Multiple company employees have indulged in significant insider trading. Pain Therapeutics, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director ROBERTSON SANFORD has acquired 50,000 shares of Pain Therapeutics, Inc. (PTIE) in trading session dated Nov. 06, 2013. These shares are worth $186,500 and were traded at $3.73 each. The SEC filing shows that FRIEDMANN NADAV performed a sale of 25,000 shares. The COO disposed these shares by way of transaction on Oct. 18, 2011. The company’s shares were given away at $4.44 per share worth to an income of some $111,000 on account of FRIEDMANN NADAV.
COO, FRIEDMANN NADAV, sold 25,000 common shares of Pain Therapeutics, Inc. (PTIE) in the open market. In a transaction dated Oct. 04, 2011, the shares were put up for sale at an average price of $4.81, raking in a sum of $120,250. After this sale, 284,255 common shares of PTIE are directly owned by the insider, with total stake valued at $227,404.
In the transaction dated Oct. 04, 2011, the great number of shares disposed came courtesy the 10% Owner; Sabretooth Master Fund, L.P. disposed a total of 382,000 shares at an average price of $4.59, amounting to approximately $1,753,380. The insider now directly owns 4,263,076 shares worth $3,410,461.
Pain Therapeutics, Inc. (PTIE) Analyst Guide
Several analysts have released their opinion on Pain Therapeutics, Inc. (NASDAQ
TIE), with 0 analysts believing it is a strong buy. Whereas 1 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 3 average brokerage recommendation.
(0)
(0)
I'm in it to win it!
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'